Novaliq Logo

Novaliq

Home - Novaliq

Who is Novaliq?

Novaliq is a pharmaceutical company committed to develop best-in-class ocular therapies.Our unique and versatile water-free technology is poised to transform established treatments. Novaliq is headquartered in Heidelberg, Germany and has an office in Cambridge, MA, USA. EyeSol®, Novaliq’s unique and proprietary water-free technology, opens completely new and intriguing opportunities to cure, relief and prevent diseases in various areas of indications for patients. Since December 2019, Novaliq has a strategic cooperation with Bausch + Lomb. In China, Novaliq has a strategic cooperation with Jiangsu Hengrui Pharmaceuticals since November 2019. In April 2019, Novaliq has founded Betaliq Inc., Tampa, USA in collaboration with BLP Management Group, LLC. Novaliq is a biopharmaceutical company focusing on the development and commercialization of first- and best-in-class ocular therapeutics based on EyeSol®, the first and only water-free technology worldwide for ophthalmology products. Our team of seasoned industry experts is driven by the single mission:.

This company is:

Manufacturer

Heidelberg, Germany

51-100 Employees

Founding year: 2007



Products & services of Novaliq

Product CyclASol - Novaliq image
Product

Verified

CyclASol - Novaliq

CyclASol® | Regulatory status of CyclASol® | Publications | Pipeline | Products | Fast and powerful anti-inflammatory dry eye drug therapy | NOV03 | NovaTears® | NovaTears®+Omega-3 | CyclASol® has the potential to change the way eye care practitioners treat patients with dry eye disease

Product Novatears+Omega-3 - Novaliq image
Product

Verified

Novatears+Omega-3 - Novaliq

NovaTears®+Omega-3 | Products | NovaTears®+Omega-3 eye-drops is the first eyedrop containing high dose of Omega-3 fatty acids (0,2%). | NovaTears® | NOV03 | CyclASol® | Next generation multi dose eye drop containing 0,2% Omega-3

Product NOV03 - Novaliq image
Product

Verified

NOV03 - Novaliq

NOV03 | Regulatory status of NOV03 | Publications | Products | NOV03 (100% perfluorohexyloctane) is the first drug developed to treat dry eye disease (DED) associated with Meibomian gland dysfunction in a highly effective way. | NovaTears® | NovaTears®+Omega-3 | CyclASol® | First drug developed to treat signs and symptoms of evaporative dry eye disease

View all products


Keywords

Advertising, Public Relations, and Related Services
Pharmaceutical
Scientific Research and Development Services
Medical and Diagnostic Laboratories
Health Care
Medical laboratories
Biotechnology
Medical research Advertising

Industries

Pharmaceuticals

Contact of Novaliq

City: Heidelberg

State: Baden-Württemberg

Country: Germany



Frequently asked questions (FAQ) about Novaliq

The company Novaliq is located in Heidelberg, Baden-Württemberg, Germany. It's worth noting that the company may has more corporate locations

As of the latest available information Novaliq has around 51-100 employees worldwide.

Novaliq was founded in 2007

The company Novaliq has it's main focus in the industries of Pharmaceuticals

Based on the founding year and the amount of employees the company Novaliq seems to be a Medium-Sized Company at the current state. Note that over time that status can change

Competitors of Novaliq

NovalGen Logo

NovalGen

United Kingdom

11-50 Employees

2019

Noyavision Pharmaceutical Group Logo

Noyavision Pharmaceutical Group

Iran

51-100 Employees

2006

Novalis Biotechnology Incubation Logo

Novalis Biotechnology Incubation

Belgium

1-10 Employees

2018

Qlaris Bio, Inc. Logo

Qlaris Bio, Inc.

United States

1-10 Employees

2019

Novaled Logo

Novaled

Germany

51-100 Employees

2001

2020 OptimEyes Logo

2020 OptimEyes

Canada

1-10 Employees

SiNOPSEE Therapeutics Logo

SiNOPSEE Therapeutics

Philippines

Nova Laboratories Limited Logo

Nova Laboratories Limited

United Kingdom

51-100 Employees

1993


Suitable topics for Novaliq

Topics which have been searched by others and may be interesting for you: